GlycoMimetics, Inc.GlycoMimetics, Inc.GlycoMimetics, Inc.

GlycoMimetics, Inc.

No trades
See on Supercharts
Market capitalization
‪139.21 M‬USD
−0.58USD
‪−36.90 M‬USD
‪10.00 K‬USD
‪58.36 M‬
Beta (1Y)
2.11

About GlycoMimetics, Inc.

CEO
Harout Semerjian
Headquarters
Rockville
Employees (FY)
35
Founded
2003
ISIN
US38000Q1022
FIGI
BBG001J1BQN9
GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease related functions of carbohydrates. The company was founded by Rachel K. King and John L. Magnani on April 4, 2003 and is headquartered in Rockville, MD.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GLYC is 1.93 USD — it has decreased by 10.88% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange GlycoMimetics, Inc. stocks are traded under the ticker GLYC.
GlycoMimetics, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
GLYC stock is 15.43% volatile and has beta coefficient of 2.11. Check out the list of the most volatile stocks — is GlycoMimetics, Inc. there?
One year price forecast for GlycoMimetics, Inc. has a max estimate of 10.00 USD and a min estimate of 3.00 USD.
GLYC earnings for the last quarter are −0.14 USD per share, whereas the estimation was −0.14 USD resulting in a 2.33% surprise. The estimated earnings for the next quarter are −0.15 USD per share. See more details about GlycoMimetics, Inc. earnings.
GlycoMimetics, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach ‪50.00 K‬ USD.
Yes, you can track GlycoMimetics, Inc. financials in yearly and quarterly reports right on TradingView.
GLYC stock has fallen by 23.00% compared to the previous week, the month change is a 34.97% fall, over the last year GlycoMimetics, Inc. has showed a 30.95% increase.
GLYC net income for the last quarter is ‪−9.08 M‬ USD, while the quarter before that showed ‪−9.20 M‬ USD of net income which accounts for 1.34% change. Track more GlycoMimetics, Inc. financial stats to get the full picture.
Today GlycoMimetics, Inc. has the market capitalization of ‪139.21 M‬, it has decreased by 12.50% over the last week.
No, GLYC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GLYC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GlycoMimetics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
GLYC reached its all-time high on Feb 15, 2018 with the price of 26.05 USD, and its all-time low was 0.51 USD and was reached on Jun 16, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has 35.00 employees. See our rating of the largest employees — is GlycoMimetics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GlycoMimetics, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GlycoMimetics, Inc. stock shows the sell signal. See more of GlycoMimetics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on GlycoMimetics, Inc. future price: according to them, GLYC price has a max estimate of 10.00 USD and a min estimate of 3.00 USD. Read a more detailed GlycoMimetics, Inc. forecast: see what analysts think of GlycoMimetics, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GlycoMimetics, Inc. EBITDA is ‪−38.45 M‬ USD, and current EBITDA margin is ‪−391.22 K‬%. See more stats in GlycoMimetics, Inc. financial statements.